Papers
2
Total Citations
19
H-Index
2
About
Dr. Jason Sea is a surgical innovator whose work centers on advancing minimally invasive treatments for renal tumors, with a particular focus on robot-assisted and image-guided technologies. His most cited study, “Comparison of Measured Renal Tumor Size Versus R.E.N.A.L. Nephrometry Score in Predicting Patient Outcomes After Robot-Assisted Laparoscopic Partial Nephrectomy” (2013, 17 citations), critically evaluated how tumor complexity scoring systems can better identify patients at risk for adverse outcomes—a key contribution to refining patient selection for challenging partial nephrectomies. Dr. Sea also pioneered the calibration of a novel, laparoscopic 12-mm ultrasound-guided high-intensity focused ultrasound (HIFU) probe for renal ablation (2015, 2 citations), demonstrating his commitment to developing less invasive, precisely targeted therapies. His research bridges the gap between surgical technique and patient safety, offering practical tools for urologists to optimize outcomes. While his citation counts reflect a focused, early-career impact, Dr. Sea’s work is foundational for surgeons seeking to balance oncologic control with renal function preservation. His contributions underscore a dedication to precision surgery and evidence-based decision-making in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2